Bundibugyo ebolavirus

RedHill Advances Opaganib as Potential Ebola Treatment Amid Rare Bundibugyo Virus Outbreak

TEL AVIV, Israel and RALEIGH, N.C., June 2, 2026 RedHill Biopharma has announced efforts to advance the clinical development...

By cGxPwire Editor
June 4, 2026

MedTech

QIAGEN Launches Bundibugyo Ebola Research Assays to Support Outbreak Surveillance

VENLO, Netherlands & GERMANTOWN, Md., May 28, 2026 QIAGEN announced the availability of two custom-designed research-use-only (RUO) QIAcuity digital...

By cGxPwire Editor
May 30, 2026

Bio-Pharma

Regeneron’s Ebola Antibody Prioritized by WHO for Bundibugyo Outbreak Research

TARRYTOWN, N.Y. | May 28, 2026 Regeneron Pharmaceuticals announced that maftivimab, the lead neutralizing antibody within its FDA-approved Ebola...

By cGxPwire Editor
May 30, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Bundibugyo ebolavirus

RedHill Advances Opaganib as Potential Ebola Treatment Amid Rare Bundibugyo Virus Outbreak

QIAGEN Launches Bundibugyo Ebola Research Assays to Support Outbreak Surveillance

Regeneron’s Ebola Antibody Prioritized by WHO for Bundibugyo Outbreak Research